A quality improvement study: Optimizing pneumococcal vaccination rates in children with cochlear implants

S Tay1, A C Bowen2, C C Blyth2

  • 1Immunisation Service, Department of Infectious Diseases, Perth Children's Hospital, Western Australia, Australia.

Vaccine
|June 19, 2022
PubMed

Insights

Children with cochlear implants often miss recommended pneumococcal vaccines. Strategies like electronic reminders and dedicated clinics significantly improved vaccination rates, reducing the risk of invasive pneumococcal disease in this vulnerable group.

Area of Science:

  • Pediatric Otolaryngology
  • Infectious Diseases
  • Vaccinology

Background:

  • Children with cochlear implants face a higher risk of invasive pneumococcal disease.
  • Guidelines recommend additional pneumococcal vaccines for these children.
  • Immunization status in this group is often suboptimal.

Purpose of the Study:

  • To assess pneumococcal immunization status and invasive pneumococcal disease rates in children with cochlear implants.
  • To evaluate the impact of vaccination reminders and a dedicated immunization clinic on vaccination rates.
  • To identify strategies for improving vaccine uptake in medically-at-risk pediatric populations.

Main Methods:

  • Quality improvement study over 12 years at a tertiary pediatric hospital.
  • Included 200 children with cochlear implants.
  • Assessed impact of electronic reminders and a nurse-led immunization clinic.

Main Results:

  • 88% of children were not up-to-date with recommended pneumococcal vaccines.
  • 2% of children developed invasive pneumococcal disease.
  • Electronic reminders increased vaccine uptake from 12% to 49%.
  • Dedicated clinic achieved 100% uptake for Prevenar13 and 81% for Pneumovax23.

Conclusions:

  • A significant proportion of children with cochlear implants remain under-vaccinated against pneumococcal disease.
  • Interventions like electronic reminders and dedicated clinics are effective in improving vaccine uptake.
  • The demonstrated model can be expanded to other at-risk pediatric groups.